BioSpace News Archive

A new report released today on Medicare Part D found the program is as popular and robust as ever, but faces challenges that could result in increased costs and limited access for millions of beneficiaries.

With an expanding portfolio of breakthrough innovations, FACIT is committed to supporting Ontario entrepreneurs through the latest round of its Prospects Oncology Fund. FACIT has selected three novel cancer therapeutic discoveries to receive early-stage capital - biotechnology start-up Talon Pharmaceuticals (“Talon”), the Drug Discovery team at the Ontario Institute for Cancer Research (“OICR”) and CCRM.

Patients at Nationwide Children’s Hospital, one of America’s largest not-for-profit freestanding pediatric health care systems, now have the latest enhancement for intravenous (IV) therapy with the installation of the ivWatch Model 400.

Directed by an Academy Award® winning filmmaker in the documentary short subject category, “Something So Rare” chronicles the lives of four people living with MPNs, rare blood cancers

New Statement Calls for Greater Support for Science Educators to Teach Evidence-based Science

Biolog-id today announced the establishment of its U.S. operational center in Atlanta.

Verseon today announces that it has received ethics committee approval and acknowledgement from the Therapeutic Goods Administration in Australia for the phase I clinical trial of VE-1902, the first clinical candidate from its novel class of precision oral anticoagulants (PROACs).

Sensus Healthcare, Inc. announced today that it has priced an underwritten public offering of 2,205,882 shares of its common stock, par value $0.01 per share, at a public offering price of $6.80 per share.

Game-Changing Information to Be Shared on Newly Launched Podcast from Global Healthcare Resources

DATATRAK International, Inc. today announced it will be exhibiting at the 2018 Society of Clinical Data Management (SCDM) Annual Conference, September 23-25 in Seattle, WA (Booth # 414).